LEADER 08749nam 2203049z- 450 001 9910557114703321 005 20231214133556.0 035 $a(CKB)5400000000040899 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69077 035 $a(EXLCZ)995400000000040899 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Nanomedicine 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (510 p.) 311 $a3-03943-058-0 311 $a3-03943-059-9 330 $aThis special issue brings together cutting edge research and insightful commentary on the currentl state of the Cancer Nanomedicine field. 606 $aTechnology: general issues$2bicssc 610 $aantibody drug conjugate (ADC) 610 $aPD-L1 610 $atumor spheroid disruption 610 $aimmune modulation 610 $adoxorubicin 610 $agraphene oxide 610 $aadsorption 610 $acathepsin D 610 $acathepsin L 610 $aanti-metastatic enzyme cancer therapy 610 $ananoparticles 610 $atargeted delivery system 610 $asiRNA 610 $aosteopontin 610 $amammary carcinoma 610 $amesenchymal stem cells (MSCs) 610 $aTAT peptide 610 $aPLGA 610 $apaclitaxel 610 $anano-engineered MSCs 610 $aorthotopic lung tumor model 610 $aintracranial glioma 610 $aimmunotherapy 610 $aCPMV 610 $aviral nanoparticles 610 $ain situ vaccine 610 $aalbumin nanoparticles 610 $amicrobubble 610 $aultrasound 610 $atheranostics 610 $ahepatocellular carcinoma 610 $aVX2 tumor 610 $aintra-arterial chemotherapy 610 $alung cancer 610 $ananomedicine 610 $aclinical status 610 $acancer therapy 610 $abreast cancer 610 $acell signaling 610 $aactive targeting 610 $apassive targeting 610 $aEPR effect 610 $aoncogenes 610 $ananoparticle 610 $adrug delivery 610 $aligand 610 $atumor targeting 610 $abiodistribution 610 $aMesoporous silica nanoparticle 610 $adrug delivery system 610 $atarget treatment 610 $alanthanide metal 610 $ahyaluronic acid 610 $ahyaluronidase 610 $adrug combination 610 $aeverolimus 610 $adual-targeting 610 $amagnetic nanoparticles 610 $amonoclonal antibodies 610 $ananostructured lipid carrier 610 $aplatelet membrane 610 $abiomimicry 610 $aplasmonic photothermal therapy 610 $agold nanorods 610 $asurgery 610 $ableeding 610 $adogs 610 $acats 610 $astimuli-responsive 610 $aDOX 610 $aSN38 610 $aCSCs 610 $asingle-walled carbon nanotubes 610 $achirality separation 610 $aNASH 610 $adrug-gene delivery 610 $anear IR hyperspectral imaging 610 $aplasmonics 610 $acopper 610 $aVEGF 610 $aglioblastoma 610 $adifferentiated neuroblastoma 610 $apeptidomimetics 610 $areal-time quantitative polymerase chain reaction (qPCR) 610 $aactin 610 $acombinatorial therapy 610 $aanticancer and antibacterial activity 610 $atemoporfin 610 $adrug-in-cyclodextrin-in-liposome 610 $ahybrid nanoparticles 610 $amulticellular tumor spheroids 610 $acyclodextrins 610 $aphotodynamic therapy article 610 $ayet reasonably common within the subject discipline 610 $aantitumor strategy 610 $abiomimetic core?shell nanoparticles 610 $aNK cell-derived exosomes 610 $afolate receptor 610 $aalbumin nanoparticle 610 $amicrofluidic 610 $acabazitaxel 610 $apolydopamine nanoparticles 610 $asize 610 $acytotoxicity 610 $airon affinity 610 $aFA-DABA-SMA 610 $aself-assembly 610 $aoncogenic proteins 610 $aintracellular disruption 610 $afolic receptor alpha 610 $apancreatic cancer 610 $aparvifloron D 610 $aalbumin 610 $aerlotinib 610 $aphotodynamic therapy 610 $alipid nanoparticles 610 $atumor vectorization 610 $averteporfin 610 $aovarian carcinomatosis 610 $aspheroids 610 $aintegrin 610 $aRGD peptide 610 $acancer diagnosis 610 $aradiotherapy 610 $ahyperthermia therapy 610 $abiomimetic 610 $ananocarrier 610 $amembrane-wrapped 610 $acancer 610 $atargeted delivery 610 $aphotothermal therapy 610 $aimaging 610 $acancer nanomedicine 610 $atumor microenvironment 610 $anano?bio interactions 610 $aclinical translation 610 $amagnetic nanowires 610 $amagnetic hyperthermia 610 $amagnetic actuation 610 $amagnetic drug targeting 610 $atitanate nanotubes 610 $agold nanoparticles 610 $avectorization 610 $acolloidal stability 610 $adocetaxel 610 $aprostate cancer 610 $amangiferin 610 $aanti-topoisomerase activity 610 $aextracellular vesicles 610 $aexosomes 610 $achemico-physical functionalization 610 $aloading 610 $atranslational medicine 610 $ananotechnology: bioengineering 610 $aanacardic acid 610 $amitoxantrone 610 $atargeted drug delivery 610 $aliposomes 610 $amelanoma 610 $aapoptosis 610 $aascorbic acid 610 $aangiogenesis 610 $aepithelial-to-mesenchymal transition 610 $ahypoxia 610 $aimmunosuppression 610 $ametabolism 610 $ananotherapeutics 610 $atumour microenvironment 610 $aDNA origami 610 $aliposome 610 $aremote loading 610 $aacute toxicity 610 $aorganoids 610 $amagnetic silica-coated iron oxide nanochains 610 $aphotothermal treatment 610 $ahyperthermia 610 $acollagen 610 $acellular microenvironment 610 $alymphadenectomy 610 $amagnetometer 610 $asentinel lymph node dissection 610 $aSPION 610 $asuperparamagnetic iron oxide nanoparticles 610 $aV?2 T cells 610 $azoledronic acid 610 $apolymeric nanoconstruct 610 $aanti-tumor immunity 610 $acolorectal carcinoma 610 $a?-cyclodextrin nanosponges 610 $aBALB-neuT mice 610 $abrain tumours 610 $aglioma 610 $ablood brain barrier 610 $apolymeric nanoparticles 610 $aPEGylation 610 $adioleoylphosphatidylethanolamine 610 $apoly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer 610 $afolate 610 $aoxidation-sensitive release 610 $acellular interaction 610 $ain vitro anti-cancer activity 610 $atriple negative breast cancer 610 $aorganotin 610 $amesoporous silica nanoparticles 610 $aMDA-MB-231 610 $atheranostic nanomaterials 610 $ananobiotechnology 610 $amolecular imaging 610 $ananosystems 610 $ananomicelles 610 $aovarian cancer 610 $atumour targeting 610 $achemotherapeutics 610 $ariboflavin 610 $avitamin B2 610 $ananomedicines 610 $asecondary structure 610 $amixed micelle 610 $apH responsive 610 $atargeted therapy 610 $aanti-cancer 610 $ashear stress 610 $aflow 610 $ain vitro 610 $atherapeutics 610 $adiagnostics 610 $aImmunotherapy 615 7$aTechnology: general issues 700 $aHoskins$b Clare$4edt$01280958 702 $aHoskins$b Clare$4oth 906 $aBOOK 912 $a9910557114703321 996 $aCancer Nanomedicine$93017749 997 $aUNINA